- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Cedars-Sinai Cancer | Strategic Alliance Partners
Cedars-Sinai Cancer in Los Angeles serves one of the most diverse regions globally. Ranked No. 7 for cancer by U.S. News & World Report 2020-2021, the center’s clinicians are committed to providing compassionate, state-of-the-art care, while its scientists are carrying out the latest translational research and groundbreaking advances. The cancer enterprise includes the Samuel Oschin Comprehensive Cancer Institute, The Angeles Clinic and Research Institute, Tower Hematology Oncology Medical Group, Torrance Memorial Hunt Cancer Center and Cedars-Sinai Tarzana.
Latest from Cedars-Sinai Cancer
Dr. Atkins on Safety Considerations For Neoadjuvant Approaches in Gastric Cancer
June 14, 2021
Video
Katelyn M. Atkins, MD, PhD, discusses safety considerations for neoadjuvant approaches in patients with gastric cancer.
Role of Adjuvant Chemoradiation Under Study in Gastric Cancer
May 16, 2021
Article
Katelyn M. Atkins, MD, PhD, examines the evolving role of radiotherapy in the treatment of patients with gastric cancer, the subgroups who might derive the most benefit from this approach, and ongoing research efforts that are seeking to address remaining questions with this modality.
Gong Gives Perspective on Sequencing Challenges Faced in Advanced HCC
May 14, 2021
Article
Jun Gong, MD, discusses the impact of the IMbrave150 trial on the advanced HCC treatment paradigm and challenges faced with sequencing.
The Future of Cancer Immunotherapy Lies in Combinational Approaches
May 06, 2021
Article
Arsen Osipov, MD, discusses the potential for ongoing research with immunotherapeutic approaches in gastrointestinal malignancies, including CAR T-cell therapy, bispecific T-cell engagers, and vaccines.
Dr. Osipov on the Role of Combination Immunotherapy Across Multiple Tumor Types
April 30, 2021
Video
Arsen Osipov, MD, discusses the role of combination immunotherapy across multiple tumor types.
Dr. Atkins on the Role of Adjuvant Chemoradiation in Gastric Cancer
April 14, 2021
Video
Katelyn M. Atkins, MD, PhD, discusses the role of adjuvant chemoradiation therapy in gastric cancer.
Dr. Lopategui on the Evolution of Targeted Therapies in NSCLC
June 05, 2020
Video
Jean Lopategui, MD, discusses the evolution of targeted therapies in non–small cell lung cancer.
Dr. Natale on the Evolution of Immunotherapy in NSCLC
May 15, 2020
Video
Ronald B. Natale, MD, discusses the evolution of immunotherapy in advanced non–small cell lung cancer.
Dr. Natale on the Evolution of Immunotherapy in NSCLC
May 14, 2020
Video
Ronald B. Natale, MD, discusses the evolution of immunotherapy in advanced non–small cell lung cancer.
Dr. Freedland on Real-World Utility of Enzalutamide in Prostate Cancer
May 12, 2020
Video
Stephen J. Freedland, MD, discusses remaining questions with the real-world utility of enzalutamide in prostate cancer.
Dr. Freedland on Real-World Utility of Enzalutamide in Prostate Cancer
May 11, 2020
Video
Stephen J. Freedland, MD, discusses remaining questions with the real-world utility of enzalutamide in prostate cancer.
Dr. Lopategui on the Evolution of Molecular Testing in NSCLC
May 05, 2020
Video
Jean Lopategui, MD, discusses the evolution of molecular testing in non–small cell lung cancer.
Dr. Reckamp on Navigating Challenges Posed by COVID-19
April 14, 2020
Video
Karen L. Reckamp, MD, MS, provides insight on how she is navigating challenges posed by the COVID-19 crisis.
Dr. Freedland on Real-World Evidence Vs PREVAIL Trial in mCRPC
March 27, 2020
Video
Stephen J. Freedland, MD, discusses how real-world evidence with the use of enzalutamide in patients with metastatic castration-resistant prostate cancer (mCRPC) compares with data from the phase III PREVAIL trial.
Dr. Freedland on the Importance of Conducting Real-World Analyses in Prostate Cancer
March 10, 2020
Video
Stephen J. Freedland, MD, discusses the importance of conducting real-world analyses in prostate cancer.
Dr. Mirhadi on Patient Populations of Lung Cancer Optimal for Radiation
March 04, 2020
Video
Amin J. Mirhadi, MD, discusses patient populations of lung cancer who should be treated with radiation therapy.
Dr. Figlin on Novel Combinations in Kidney Cancer Treatment
March 02, 2020
Video
Robert A. Figlin, MD, discusses novel combinations in the treatment of patients with kidney cancer.
Dr. Reckamp on Targeted Therapy Options for Rare Mutations in NSCLC
February 28, 2020
Video
Karen L. Reckamp, MD, MS, discusses targeted therapy options for rare mutations in non–small cell lung cancer.
Immunotherapy Makes Waves in Small Cell Lung Cancer
February 28, 2020
Article
Alain C. Mita, MD, discusses the impact of immunotherapy in the frontline and recurrent settings for patients with small cell lung cancer.